Medtronic completes first Hugo case in the US
CEO Geoff Martha said that while Hugo may not “move the needle” for Medtronic’s surgical business yet, the system is growing “pretty fast.”
Uncategorized
Amwell expects lower revenue in 2026
The health technology company has divested assets and refocused on its core offering, resulting in a smaller top line, executives said on an earnings call Thursday.
Disc’s Regulatory Comeback Plan for Rejected Drug Relies on Old FDA Leadership
Disc Medicine’s leadership tried to express optimism that its rare disease therapy bitopertin can be approved based on a Phase 3 trial set to begin shortly. However, analysts are worried that the protocol was developed with former FDA leaders.
Disc’s Regulatory Comeback Plan for Rejected Drug Relies on Old FDA Leadership Read More »
Compass’ Psychedelic Shows Durability ‘In-Spades’ as Path to FDA Clears
Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical Officer Guy Goodwin. By providing 26 weeks’ worth of such data instead of the requested 12, the company is delivering “in spades,” he said.
Compass’ Psychedelic Shows Durability ‘In-Spades’ as Path to FDA Clears Read More »
Descubren un planeta que desafía las teorías sobre la formación planetaria
Se ha descubierto una característica inusual en el sistema planetario que rodea a una estrella llamada LHS 1903. El orden de sus planetas desafía las teorías actualmente aceptadas sobre formación planetaria. Todo apunta a que el planeta más lejano de ese sistema es …
Descubren un planeta que desafía las teorías sobre la formación planetaria Read More »
El virus del herpes labial puede provocar alteraciones como las del Mal de Alzheimer
La enfermedad de Alzheimer es uno de los mayores retos sanitarios y sociales en la actualidad. Entre sus señales biológicas más conocidas destacan la acumulación anormal de la proteína beta‑amiloide y las alteraciones químicas anómalas de una segund …
El virus del herpes labial puede provocar alteraciones como las del Mal de Alzheimer Read More »
As FDA Moves Away From Animal Testing, AI and Organoids Can Shine
Johns Hopkins’ Thomas Hartung discusses how drug discovery and development will change under evolving regulatory policies that embrace AI technology as well as organoid and other non-animal models of human biology.
As FDA Moves Away From Animal Testing, AI and Organoids Can Shine Read More »
Ocular’s Hydrogel Beats Regeneron’s Eylea in Wet AMD Study, Plots Path to FDA
Following the successful late-stage study in wet age-related macular degeneration, Ocular plans to meet with the FDA to determine a regulatory path for Axpaxli.
Ocular’s Hydrogel Beats Regeneron’s Eylea in Wet AMD Study, Plots Path to FDA Read More »
Does Vaxart Hold the Key to the Elusive Norovirus Vaccine?
Competing with giants like Takeda and Moderna, the plucky biotech believes it has unlocked a future with an easy, yearly oral vaccine.
Does Vaxart Hold the Key to the Elusive Norovirus Vaccine? Read More »
Material cristalino que se autorrepara a las temperaturas de otros mundos
Se ha descubierto un revolucionario material orgánico cristalino capaz de autorrepararse en una gama de temperaturas que abarca desde unos 150 grados centígrados hasta casi 200 bajo cero. Su operatividad a temperaturas tan extremas lo hace particularmente interesante para aplicaciones …
Material cristalino que se autorrepara a las temperaturas de otros mundos Read More »